Pluripotent cells within embryonal carcinoma (EC) can differentiate or upon treatment with particular agencies. c-src signaling via SHP-2 activation and regulation of Nanog Oct4 and Cripto-1 expressions. Introduction Embryonal carcinoma (EC) is a germ line tumor consisting of Gracillin cells that can be induced to differentiate with brokers such as retinoic acid (1). The malignant… Continue reading Pluripotent cells within embryonal carcinoma (EC) can differentiate or upon treatment